The impact of perinatal severe acute respiratory syndrome coronavirus 2 infection during the peripartum period

Published:October 20, 2020DOI:https://doi.org/10.1016/j.ajogmf.2020.100267
      Our large integrated health system in New York City implemented universal screening for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing the coronavirus disease 2019 (COVID-19) pandemic in 2019 and 2020, of all women admitted to the labor service on March 25, 2020. We also implemented universal screening of all neonates born to mothers who were SARS-CoV-2 positive. Here, we report perinatal SARS-CoV-2 infection outcomes in our population during the complete peak period of the COVID-19 incidence and inpatient volume in the New York City area, March 25, 2020, to May 15, 2020. We also describe how perinatal SARS-CoV-2 was tracked with the number of COVID-19 hospitalizations in our hospitals. This information is critically important in planning for future COVID-19 outbreaks either in regions previously minimally impacted by the virus or in an anticipated future resurgence. This study aimed to assess the impact of SARS-CoV-2 on delivery and postpartum services in a single health system in New York City during the peak period of the COVID-19 pandemic. Specifically, we were interested in the clinical impact of SARS-CoV-2 infection on the adverse pregnancy outcomes of stillbirth and preterm birth during the peak period of the pandemic. We were also interested in the volume of patients who were SARS-CoV-2 positive presenting to our labor floors compared with the volume of COVID-19 admissions to other hospital services as we prepare for a possible second wave of the pandemic this fall. Our goal with this study was to provide data necessary for such service preparedness.
      To read this article in full you will need to make a payment

      References

        • Sutton D.
        • Fuchs K.
        • D’Alton M.
        • Goffman D.
        Universal screening for SARS-CoV-2 in women admitted for delivery.
        N Engl J Med. 2020; 382: 2163-2164
        • Campbell K.H.
        • Tornatore J.M.
        • Lawrence K.E.
        • et al.
        Prevalence of SARS-CoV-2 among patients admitted for childbirth in southern Connecticut.
        JAMA. 2020; 323: 2520-2522
        • Khoury R.
        • Bernstein P.S.
        • Debolt C.
        • et al.
        Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers.
        Obstet Gynecol. 2020; 136: 273-282
        • Khalil A.
        • von Dadelszen P.
        • Draycott T.
        • Ugwumadu A.
        • O’Brien P.
        • Magee L.
        Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic.
        JAMA. 2020; ([Epub ahead of print])
        • Martin J.A.
        • Hamilton B.E.
        • Osterman M.J.K.
        • Driscoll A.K.
        Births: final data for 2018.
        Natl Vital Stat Rep. 2020; 68: 1-47
        • Thomas P.
        • Alexander P.E.
        • Ahmed U.
        • et al.
        Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review.
        J Matern Fetal Neonatal Med. 2020; : 1-8
        • Grimminck K.
        • Santegoets L.A.M.
        • Siemens F.C.
        • Fraaij P.L.A.
        • Reiss I.K.M.
        • Schoenmakers S.
        No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient.
        BMJ Case Rep. 2020; 13: e235581